Merck KGaA (MRK) Given Average Rating of “Hold” by Analysts
Merck KGaA (FRA:MRK) has been given an average rating of “Hold” by the twenty-four research firms that are presently covering the stock, MarketBeat Ratings reports. Thirteen investment analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is €109.43 ($128.75).
MRK has been the subject of several research analyst reports. Nord/LB reiterated a “neutral” rating on shares of Merck KGaA in a research report on Wednesday, June 28th. Oddo Bhf set a €125.00 ($147.06) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Friday, September 29th. Morgan Stanley set a €103.00 ($121.18) price objective on Merck KGaA and gave the stock a “neutral” rating in a research report on Monday, September 25th. Credit Suisse Group set a €106.00 ($124.71) price objective on Merck KGaA and gave the stock a “neutral” rating in a research report on Wednesday, July 26th. Finally, Goldman Sachs Group, Inc. (The) set a €105.00 ($123.53) price objective on Merck KGaA and gave the stock a “neutral” rating in a research report on Thursday, August 17th.
TRADEMARK VIOLATION NOTICE: This news story was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/merck-kgaa-mrk-given-average-rating-of-hold-by-analysts/1623167.html.
Shares of Merck KGaA (MRK) opened at 95.50 on Wednesday. The company has a 50-day moving average of €95.16 and a 200-day moving average of €101.72. Merck KGaA has a 1-year low of €89.00 and a 1-year high of €115.00. The firm has a market cap of €41.52 billion and a PE ratio of 24.90.
Merck KGaA Company Profile
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.